Fig. 1

Survival curves and progression-free survival curves in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei. (a) Survival for LG-MCP patients with or without HIPEC after CRS. (b) Survival for all patients with or without HIPEC after CRS. (c) Progression-free survival for LG-MCP patients with or without HIPEC after CRS. (d) Progression-free survival for all patients with or without HIPEC after CRS. (e) Survival for different pathological grade in appendiceal pseudomyxoma peritonei. (f) Progression-free survival for different pathological grade in appendiceal pseudomyxoma peritonei